
Acquisition - February 12, 2024
RaySearch acquires product from Pharmacolog
RaySearch have announces the acquisition of DrugLog from Pharmacolog for the purchase price of SEK 7 million. DrugLog is a solution for verifying the identity and concentration of compounded injectable medications, used for cancer treatment with cytostatic drugs (chemotherapy). Through this agreement, RaySearch acquires full ownership of all rights to the product for its application […]

Acquisition - February 6, 2024
Novo Holdings to acquire Catalent
Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at USD 16.5 billion on an enterprise value basis. Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, will acquire all outstanding shares of CDMO Catalent for USD 63.50 per share […]

Acquisition - January 16, 2024
Key2Compliance acquired by GBA Group
With the acquisition GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. “As we have set ourselves the goal of being a broad-based service provider for medical devices, Key2Compliance, with its consulting and training services and expertise, is a perfect fit for […]

Acquisition - January 7, 2024
AstraZeneca to acquire Gracell
AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases. The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a novel, clinical-stage FasTCAR-enabled BCMA and CD19 dual-targeting autologous chimeric antigen receptor T-cell (CAR-T) […]

Acquisition - December 12, 2023
AstraZeneca to acquire Icosavax
AstraZeneca has entered into a definitive agreement to acquire Icosavax, a US-based clinical-stage biopharma company focused on developing vaccines using a protein virus-like particle (VLP) platform. The proposed acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus (RSV), strengthening AstraZeneca’s Vaccines & Immune Therapies late-stage pipeline with Icosavax’s lead investigational vaccine candidate, IVX-A12, the […]

Acquisition - December 11, 2023
Mentice enters agreement to acquire all substantial assets from Biomodex
The global Biomodex business reached a total turnover of EUR 2.2 million in 2022. Biomodex specializes in biorealistic 3D printing and flow systems for interventional procedures, with a platform geared towards clinical use and patient-specific simulation. As part of the acquisition, Mentice will also retain key employees of Biomodex. “Biomodex is truly a quality product […]